US Broker Ratings

Canopy Growth Corporation (CGC) Investor Outlook: Exploring a 55% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), a prominent player in the cannabis and hemp industry, is capturing investor attention with its significant potential upside of 55.51%, according to analyst ratings. Despite..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Ups and Downs of a $5.66 Billion Biotech Powerhouse

Erasca, Inc. (NASDAQ: ERAS) stands as a notable player in the biotechnology sector, particularly within the burgeoning field of precision oncology. With a strategic focus on therapies targeting RAS/MAPK pathway-driven..

UroGen Pharma Ltd. (URGN) Stock Analysis: Assessing a 67.88% Potential Upside in the Biotech Sector

UroGen Pharma Ltd. (NASDAQ: URGN) is gaining attention for its significant potential upside in the biotechnology sector, with analysts forecasting a notable 67.88% increase from its current price of $21.51..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a 185.71% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), headquartered in Petah Tikva, Israel, is making waves in the healthcare sector, particularly within the medical devices industry, with its innovative approach to digital X-ray..

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Potential 85% Upside Awaits Investors

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands out as a notable player in the biotechnology sector, with a primary focus on developing innovative treatments for gastrointestinal diseases. With a market capitalization..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Player with 59.70% Upside Potential

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is making waves in the biotechnology sector with its innovative therapies aimed at enhancing the lives of patients with hematologic disorders and cancer. As a..

Absci Corporation (ABSI) Stock Analysis: Exploring a 153% Potential Upside in Biotechnology

Absci Corporation (NASDAQ: ABSI) is attracting considerable attention from the investment community, thanks to its significant potential upside of 153.27% based on current analyst ratings. As a clinical-stage biopharmaceutical company..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Unveiling a 139% Upside Potential in the Medical Device Sector

Investors looking for opportunities in the healthcare sector might find ClearPoint Neuro Inc. (NASDAQ: CLPT) an intriguing prospect. With a focus on minimally invasive surgical procedures in the brain, this..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Integer Holdings Corporation (ITGR) Stock Analysis: Insights into Its 9.56% Potential Upside and Market Position

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to a company with robust growth..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech Gem with 215% Upside Potential

Investors looking for promising opportunities in the biotech sector should consider Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the field of cell therapies. With a market capitalization of..

Alkermes plc (ALKS) Stock Analysis: Key Insights on Its 32.60% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, primarily focuses on drug manufacturing in the specialty and generic segments. Headquartered in Dublin, Ireland, this biopharmaceutical company has..

Nuvalent, Inc. (NUVL): Investor Outlook with a 38.59% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector with its innovative approach to cancer treatment, particularly in addressing treatment resistance and CNS-related challenges. As a clinical-stage biopharmaceutical..

Cytokinetics, Incorporated (CYTK)

⚠️ No article content returned.

..

Guardant Health, Inc. (GH) Stock Report: Exploring a Potential 65% Upside

Investors keeping a watchful eye on the healthcare sector might find Guardant Health, Inc. (NASDAQ: GH) an intriguing prospect, with a potential upside of 65.05% according to analyst ratings. As..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unraveling the 79% Potential Upside in the Biotech Innovator

Vaxcyte, Inc. (NASDAQ: PCVX), a trailblazer in the biotechnology space, has been capturing the attention of investors with its innovative approach to vaccine development. As a clinical-stage company focused on..

Merit Medical Systems, Inc. (MMSI) Investor Outlook: Strong Buy Ratings and 48% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a distinguished name in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors. The company’s robust market presence,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating a 63.13% Potential Upside in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This Boston-based company, with a market capitalization of $5.76 billion, is..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Stable Path in the Healthcare Market

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, has carved out a niche in the medical instruments and supplies industry. With a market cap of $16.97 billion,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Insights Into Its Recent Surge and Market Position

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has been capturing attention on the investment landscape, thanks to its remarkable journey in the healthcare sector. As a Hong Kong-based company specializing in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds